• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.14% Nasdaq Down0.35%

    More On PAB.AX



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Patrys Limited (PAB.AX)

    0.01 Up 0.00(33.33%) Sep 2
    Add to Portfolio
    ProfileGet Profile for:
    Patrys Limited
    Equitable House
    Level 6
    Melbourne, VIC 3000
    Australia - Map
    Phone: 61 3 9670 3273
    Fax: 61 3 9670 3247
    Website: http://www.patrys.com

    Index Membership:N/A
    Full Time Employees:10

    Business Summary 

    Patrys Limited develops natural human antibody therapeutics for the treatment of cancer in Australia. The company’s clinical products include PAT-SM6, a natural human antibody used for the treatment of multiple types of cancer, including solid tumors, such as melanoma, breast, colon, and pancreatic, as well as blood-based cancers that include multiple myeloma; and PAT-SC1 for treating gastric cancer and solid tumors. It also has late stage preclinical products, such as PAT-LM1, a natural human antibody that is used in the treatment for multiple types of cancer against colon, lung, breast, ovary, and pancreatic cancers. The company was founded in 2006 and is headquartered in Melbourne, Australia.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Patrys Limited

    Key Executives 
    Mr. Roger McPherson CPA, GAICD,
    Chief Operating Officer
    Dr. James A. Campbell Ph.D., M.B.A.,
    Chief Exec. Officer, Managing Director and Director
    Dr. Deanne Greenwood Ph.D., MBA,
    VP of Bus. Devel. & Intellectual Property
    Dr. Frank Hensel Ph.D.,
    VP of R&D and Managing Director of Patrys GmbH
    Ms. Valentina Dubljevic MBB, BSc ,
    VP of Scientific & Clinical Devel.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.